Cell Culture Market to reach US$16.85 billion in 2018 Through Use of Live Model Systems:Transparency Market Research

The global cell culture market is currently expected to grow at a CAGR of 10.3% from 2012 to 2018, according to a report published by Transparency Market Research (TMR). The market was valued to be US$8.5 billion in 2012 and if the CAGR holds true, the market should reach an overall value of US$16.85 billion in 2018.

Browse the full Cell Culture Market Report at http://www.transparencymarketresearch.com/cell-culture-market.html

The TMR report, titled “Cell Culture Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018”, reveals key aspects to consider while formulating any strategy within the global cell culture market.

According to the report, the major factor driving the global cell culture market is a shifting preference towards performing drug discovery and evaluation with the help of live model systems. Other drivers include reagents and media free of animal-derived components and biosimilars, and advanced biologics that are produced by biopharmaceutical manufacturers. The growth of the global cell culture market is also attributed to the escalating demand for automated cell culture systems and processes.

“The rise in demand in the global cell culture market is actually expected to create a market shift towards research and manufacturing contracts that will fulfill them in a more efficient manner,” states a TMR analyst, based on findings of the research.

The fastest-growing sector in the global cell culture market is serum-free media, which is forecast to register a CAGR of 21.1% from 2012 to 2018. This segment is being fueled by the growing demand for serum-free, chemically-defined, and specialty media. Another segment that is expanding rapidly is bioreactor and culture systems, which is proving to be favorable in terms of both revenue and CAGR.

Browse the full Press Release: http://www.transparencymarketresearch.com/pressrelease/cell-culture-market.htm

Life Technologies Corporation held the largest market share in the global cell culture market in 2011. Other key players in the global cell culture market include EMD Millipore, BD, Thermo Fisher Scientific, Inc., Sigma Aldrich Corporation, Lonza Group, Life Technologies Corporation, and Corning Biosciences.

The report’s geographical analysis reveals that the largest regional share in the global cell culture market belonged to North America in 2011. Factors that drive this regional market are presence of a large number of top companies in the field, rising expenses towards healthcare, and easy availability of advanced technologies in the field of biotechnology.

The fastest-growing region in the global cell culture market is Asia Pacific, which is doing so at a CAGR of 15.6%. This regional market is driven by emerging small players that are currently operating at a regional level and lower costs of operation in comparison to developed economies.

Request a Sample of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405

Cell culture is largely used in applications such as model systems development for research, analysis of the mechanism of cell structures, and new avenues of drug discovery for treating previously incurable diseases such as Alzheimer’s.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Polymerase Chain Reaction Market Expected to Reach USD 9.6 Billion Globally in 2020

According to a new market report published by Transparency Market Research “Polymerase Chain Reaction (PCR) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, the global PCR market was valued at USD 6.1 billion in 2013 and is expected to grow at a CAGR of 6.6% from 2014 to 2020, to reach an estimated value of USD 9.6 billion by 2020.

Polymerase chain reaction (PCR) is an indispensible amplification technique in clinical and life sciences. The technique is a comparatively precise and robust method that relies on the polymerase enzyme to exponentially amplify trace amounts of DNA/RNA fragments by creating many identical or near identical copies. PCR finds wide range of applications in disease diagnosis, gene library generation, DNA sequencing, cloning, mutagenesis, bacteria and virus detection, and more.

PCR methods have revolutionized the process of disease diagnosis by enabling early and precise diagnosis of pathogens and provide accurate therapeutic treatments. Several molecular diagnostic assays have been developed recently using a variety of PCR technologies such as Abbott’s RealTime HCV Genotype II PCR assay and Roche’s COBAS HPV test. Major growth drivers include increasing applications of PCR in forensic science, enhanced automation, rising demand for amplification technologies, and research intensive investment by leading biotechnology and pharmaceutical companies. In addition, advancements in PCR technology assisting in personalized medicine is expected to impact growth of the PCR market. At present, at least 6 PCR tests are available for personalized medicine in cancer patients. The examples include Oncotype Dx Breast Cancer Assay (Genomic Health), TheraScreen EGFR (Dx) and BCR-ABL Mutation Analysis Test (Genzyme Genetics).

The global PCR market has been segmented based on the product types, end-users and application. Based on the types of products, the global PCR market has been segmented into two categories: PCR instruments, and PCR reagents and consumables. Among the products segment, reagents and consumables was the largest segment in 2013, accounting for 67% of the global PCR market due to the rising preference for specific reaction dependent reagents and master mixes. Among various end-users of PCR, academics and research organizations accounted for the largest share in 2013, followed by clinical diagnostic labs and hospitals. Based on applications, the market is categorized into life sciences, clinical diagnostics and others.

Geographically, the market has been segmented into four regions: North America, Europe, Asia Pacific and Rest of the World. The global PCR market is driven by a large number of patients suffering from malignant diseases such as leukemia and lymphoma, bacterial and viral infections, and metabolic diseases as well as the ongoing research on the causes and treatment of these diseases. In terms of revenue, North America was the largest market in 2013, followed by Europe. The PCR market in North America was valued at USD 2,614 million in 2013 and is expected to reach USD 3,944.6 million by 2020. In addition, factors such as growing population in emerging economies, rising healthcare awareness and increasing investment in life science research would increase the demand for PCR technologies, especially in countries of Asia Pacific.

Key players operating in this market include Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Inc., Agilent Technologies, Sigma-Aldrich Corporation, Beckman Coulter, Bio-Rad Laboratories, Affymetrix, Inc., GE Healthcare, QIAGEN and Becton Dickinson & Company.

Browse the full Polymerase Chain Reaction (PCR) Market :http://www.transparencymarketresearch.com/pcr-technologies.html

 

The global PCR market is segmented as follows:

Global PCR Market Revenue (USD Million), by Products

Instruments

Standard PCR Systems

Real Time PCR Systems

Digital PCR Systems

Reagents and Consumables

Global PCR Market Revenue (USD Million), by End-Users

Pharmaceutical and Biotechnology Industries

Clinical Diagnostics Labs and Hospitals

Academic and Research Organizations

Global PCR Market Revenue (USD Million), by Applications

Clinical Diagnostics

Life Sciences

Others

Global PCR Market Revenue (USD Million), by Geography

North America

Instruments

Reagents and Consumables

Europe

Instruments

Reagents and Consumables

Asia Pacific

Instruments

Reagents and Consumables

Rest of World

Instruments

Reagents and Consumables

Request a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=830

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket Ghumare

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Platelet Rich Plasma Market Expected to Reach USD 0.35 Billion Globally in 2020: Transparency Market Research

Platelet Rich Plasma Market (By Types: Pure-Platelet Rich Plasma, Leukocyte-Platelet Rich Plasma and Leukocyte-Platelet Rich Fibrin; By Origin: Autologus, Allogenic and Homologus; By Applications: Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery and Other Surgeries) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020

According to a new market report published by U.S. based market research company, Transparency Market Research “Platelet Rich Plasma Market - Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020” the global platelet rich plasma market was valued at USD 0.16 billion in 2013 and is estimated to reach a market value of USD 0.35 billion in 2020 growing at a CAGR of 11.9% from 2014 to 2020.

Browse the full Platelet Rich Plasma Market Report at http://www.transparencymarketresearch.com/platelet-rich-plasma-market.html

Increasing number of patients suffering from orthopedic injuries, rising number of cosmetic surgeries, growing awareness about advantages and applications of PRP products and introduction of new devices and application areas are considered as the important factors driving the growth of this market. PRP products are used for improving the rate of injury healing process in sports and orthopedic diseases and as dermal fillers in cosmetic industries. Moreover, growing geriatric population is another important factor propelling the PRP market growth during the forecast period from 2014 to 2020.

In 2013, P-PRP segment is the largest type of PRP utilized globally and held more than 60% of market share in the global PRP market. Rich content of platelets and growth factors and conventional type of PRP are the key factors that contributed in the dominance of P-PRP segment. However, L-PRF is anticipated to be the fastest growing segment during the forecast period from 2014 to 2020. Large number of stem cells and leukocytes and rapid healing of injuries are the factors expected to boost growth of this market segment.

Orthopedic surgery was the largest application segment in 2013, accounting for more than 30% of the global PRP market. The dominance of this application segment was due to large number of orthopedic and sports injuries, growing geriatric population and high efficiency of PRP in treating orthopedic injuries. Multiple applications of PRP in cosmetic surgeries and its cost-effectiveness are the prominent factors catalyzing growth of this market in cosmetic surgery.

Autologus PRP accounted for the largest share of the global PRP market in 2013. However, the autologus PRP segment is anticipated to lose market share during the forecast period due to increasing emphasis on allogenic blood derived PRP products. Thus, allogenic PRP segment is expected to witness the highest growth rate during the forecast period from 2014 to 2020 due to reduced time of wound healing and high concentration of growth factors.

Browse the full Press Release:http://www.transparencymarketresearch.com/pressrelease/platelet-rich-plasma-market.htm

platelet-rich-plasma-market

Geographically, in 2013 North America dominated the global PRP market and held more than 50% of the market share. Factors such as increasing number of cosmetic and orthopedic surgeries, key players domiciled in the region and strong awareness about PRP therapy and devices are supporting the dominance of the region. However, Asia-Pacific is estimated to witness strong growth and emerge as the most promising and fastest growing market during the forecast period from 2014 to 2020. The growth is expected to be driven by factors such as rapidly growing medical tourism, wide presence of local players, high geriatric population and growing awareness about PRP therapy.

The global PRP market is dominated by selective players such as Harvest Technologies Corp., Biomet, Inc., Arthrex, Inc., Arteriocyte Medical Systems Inc. and Others. Harvest Technologies Corp. w Arthrex, Inc. and Biomet, Inc. are the key players that dominated the global PRP market. Efficient PRP products and wide distribution networks are some of the key strategies adopted by these market players. Other important market players include Dr. PRP America LLC, EmCyte Corporation, Regen Lab SA, Exactech, Inc. and Cesca Therapeutics, Inc.

The global Platelet Rich Plasma (PRP) market is segmented as follows:

Global Platelet Rich Plasma (PRP) Market, by Types

Pure-Platelet Rich Plasma (P-PRP)

Leukocyte-Platelet Rich Plasma (L-PRP)

Leukocyte-Platelet Rich Fibrin (L-PRF)

Global Platelet Rich Plasma (PRP) Market, by Origin

Autologus

Homologus

Allogenic

Global Platelet Rich Plasma (PRP) Market, by Applications

Orthopedic Surgery

Cosmetic Surgery

General Surgery

Neurosurgery

Other Surgeries (Oral and Maxillofacial, Cardiothoracic, Periodontal and Urological)

Global Platelet Rich Plasma (PRP) Market, by Geography

North America

Europe

Asia-Pacific

Rest of the World (RoW)

Request a Sample of this Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4021

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector — such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Mr. Nachiket Ghumare

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/